Companies researching Veklury (remdesivir)

Veklury, the brand name for the antiviral drug remdesivir developed by Gilead Sciences, is given by intravenous injection and is authorized for use in specific COVID‑19 patients.

List of companies that research Veklury (remdesivir)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United States

Biotechnology Research

15k

$27B

Veklury (remdesivir)

Country flag

United Kingdom

Higher Education

2.2k

$3B

Veklury (remdesivir)

Country flag

France

Research Services

23k

$675M

Veklury (remdesivir)

Country flag

United States

Higher Education

17k

Veklury (remdesivir)

Showing top companies out of 6 that research Veklury (remdesivir). Get the full list on TheirStack.

Frequently asked questions